{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T16:03:49Z","timestamp":1704384229714},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s11938-006-0015-6","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T17:13:48Z","timestamp":1180890828000},"page":"331-342","source":"Crossref","is-referenced-by-count":10,"title":["Treatment of functional diarrhea"],"prefix":"10.1007","volume":"9","author":[{"given":"Evan S.","family":"Dellon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Ringel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"15_CR1","first-page":"351","volume-title":"Rome II: the Functional Gastrointestinal Disorders","author":"WG Thompson","year":"2000","unstructured":"Thompson WG, Longstreth G, Drossman DA, et al.: Functional bowel disorders and functional abdominal pain. In Rome II: the Functional Gastrointestinal Disorders, edn 2. Edited by Drossman DA, Corazziari E, Talley NJ, et al. McLean, VA: Degnon Associates; 2000:351\u2013432. This is the definitive source on the functional bowel disorders. It will be updated with the Rome III criteria in the near future.","edition":"edn 2"},{"key":"15_CR2","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1053\/gast.2002.37095","volume":"123","author":"DA Drossman","year":"2002","unstructured":"Drossman DA, Camilleri M, Mayer EA, Whitehead WE: AGA technical review on irritable bowel syndrome. Gastroenterology 2002, 123:2108\u20132131. This is a comprehensive review and bibliography for IBS. It does not touch on FD, but many of the treatments used in both conditions are outlined here.","journal-title":"Gastroenterology"},{"key":"15_CR3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.gastro.2004.05.028","volume":"127","author":"LR Schiller","year":"2004","unstructured":"Schiller LR: Chronic diarrhea. Gastroenterology 2004, 127:287\u2013293. This is an exhaustive discussion of the clinical presentation, etiology, and evaluation of chronic diarrhea.","journal-title":"Gastroenterology"},{"key":"15_CR4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1542-3565(04)00003-5","volume":"2","author":"M Camilleri","year":"2004","unstructured":"Camilleri M: Chronic diarrhea: a review on pathophysiology and management for the clinical gastroenterologist. Clin Gastroenterol Hepatol 2004, 2:198\u2013206.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"15_CR5","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0016-5085(99)70513-5","volume":"116","author":"KD Fine","year":"1999","unstructured":"Fine KD, Schiller LR: AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999, 116:1464\u20131486.","journal-title":"Gastroenterology"},{"key":"15_CR6","unstructured":"Evaluation and management of chronic diarrhea: an algorithmic approach. http:\/\/www.medscape.com\/ viewprogram\/4579_pnt. Accessed January 19, 2006."},{"key":"15_CR7","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1572-0241.1999.01437.x","volume":"94","author":"SJ Vanner","year":"1999","unstructured":"Vanner SJ, Depew WT, Paterson WG, et al.: Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol 1999, 94:2803\u20132807.","journal-title":"Am J Gastroenterol"},{"key":"15_CR8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1053\/gast.2002.34755","volume":"123","author":"JA Tibble","year":"2002","unstructured":"Tibble JA, Sigthorsson G, Foster R, Forgacs I: Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002, 123:450\u2013460.","journal-title":"Gastroenterology"},{"key":"15_CR9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1023\/B:DDAS.0000026300.47363.3b","volume":"49","author":"OA Adeniji","year":"2004","unstructured":"Adeniji OA, Barnett CB, DiPalma JA: Durability of the diagnosis of irritable bowel syndrome based on clinical criteria. Dig Dis Sci 2004, 49:572\u2013574.","journal-title":"Dig Dis Sci"},{"key":"15_CR10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1365-2036.2004.02001.x","volume":"19","author":"BD Cash","year":"2004","unstructured":"Cash BD, Chey WD: Review article: irritable bowel syndrome-an evidence-based approach to diagnosis. Aliment Pharmacol Ther 2004, 19:1235\u20131245.","journal-title":"Aliment Pharmacol Ther"},{"key":"15_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00002018-200022010-00005","volume":"22","author":"O Chassany","year":"2000","unstructured":"Chassany O, Michaux A, Bergmann JF: Drug-induced diarrhoea. Drug Saf 2000, 22:53\u201372.","journal-title":"Drug Saf"},{"key":"15_CR12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11894-005-0003-3","volume":"7","author":"MJ Farthing","year":"2005","unstructured":"Farthing MJ: Functional diarrhea. Curr Gastroenterol Rep 2005, 7:350\u2013357.","journal-title":"Curr Gastroenterol Rep"},{"key":"15_CR13","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/0016-5085(91)90080-5","volume":"101","author":"G Bazzocchi","year":"1991","unstructured":"Bazzocchi G, Ellis J, Villanueva-Meyer J, et al.: Effect of eating on colonic motility and transit in patients with functional diarrhea. Simultaneous scintigraphic and manometric evaluations. Gastroenterology 1991, 101:1298\u20131306.","journal-title":"Gastroenterology"},{"key":"15_CR14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4065\/72.4.323","volume":"72","author":"F Charles","year":"1997","unstructured":"Charles F, Phillips SF, Camilleri M, Thomforde GM: Rapid gastric emptying in patients with functional diarrhea. Mayo Clin Proc 1997, 72:323\u2013328.","journal-title":"Mayo Clin Proc"},{"key":"15_CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1542-3565(04)00726-8","volume":"3","author":"SP Dunlop","year":"2005","unstructured":"Dunlop SP, Coleman NS, Blackshaw E, et al.: Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005, 3:349\u2013357.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"15_CR16","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.clinthera.2005.11.012","volume":"27","author":"RJ Gilkin Jr","year":"2005","unstructured":"Gilkin RJ, Jr: The spectrum of irritable bowel syndrome: a clinical review. Clin Ther 2005, 27:1696\u20131709.","journal-title":"Clin Ther"},{"key":"15_CR17","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/gast.2002.32392","volume":"122","author":"WE Whitehead","year":"2002","unstructured":"Whitehead WE, Palsson O, Jones KR: Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? Gastroenterology 2002, 122:1140\u20131156.","journal-title":"Gastroenterology"},{"key":"15_CR18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.gtc.2005.02.007","volume":"34","author":"P Bercik","year":"2005","unstructured":"Bercik P, Verdu EF, Collins SM: Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am 2005, 34:235\u2013245.","journal-title":"Gastroenterol Clin North Am"},{"key":"15_CR19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/gut.39.4.551","volume":"39","author":"DA Gorard","year":"1996","unstructured":"Gorard DA, Gomborone JE, Libby GW, Farthing MJ: Intestinal transit in anxiety and depression. Gut 1996, 39:551\u2013555.","journal-title":"Gut"},{"key":"15_CR20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.gtc.2005.02.004","volume":"34","author":"OS Palsson","year":"2005","unstructured":"Palsson OS, Drossman DA: Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments. Gastroenterol Clin North Am 2005, 34:281\u2013303.","journal-title":"Gastroenterol Clin North Am"},{"key":"15_CR21","doi-asserted-by":"crossref","unstructured":"Monsbakken KW, Vandvik PO, Farup PG: Perceived food intolerance in subjects with irritable bowel syndrome-etiology, prevalence and consequences. Eur J Clin Nutr 2005 [Epub ahead of print].","DOI":"10.1038\/sj.ejcn.1602367"},{"key":"15_CR22","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/gut.2003.037697","volume":"53","author":"W Atkinson","year":"2004","unstructured":"Atkinson W, Sheldon TA, Shaath N, Whorwell PJ: Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004, 53:1459\u20131464.","journal-title":"Gut"},{"key":"15_CR23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1080\/00365520510015593","volume":"40","author":"S Zar","year":"2005","unstructured":"Zar S, Mincher L, Benson MJ, Kumar D: Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome. Scand J Gastroenterol 2005, 40:800\u2013807.","journal-title":"Scand J Gastroenterol"},{"key":"15_CR24","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/j.1572-0241.2005.00288.x","volume":"100","author":"YA Saito","year":"2005","unstructured":"Saito YA, Locke GR 3rd, Weaver AL, et al.: Diet and functional gastrointestinal disorders: a populationbased case-control study. Am J Gastroenterol 2005, 100:2743\u20132748.","journal-title":"Am J Gastroenterol"},{"key":"15_CR25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/01.mog.0000181712.81657.0a","volume":"21","author":"MA Kalliomaki","year":"2005","unstructured":"Kalliomaki MA: Food allergy and irritable bowel syndrome. Curr Opin Gastroenterol 2005, 21:708\u2013711.","journal-title":"Curr Opin Gastroenterol"},{"key":"15_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.0269-2813.2004.01862.x","volume":"19","author":"CJ Bijkerk","year":"2004","unstructured":"Bijkerk CJ, Muris JW, Knottnerus JA, et al.: Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004, 19:245\u2013251.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 11","key":"15_CR27","first-page":"S7","volume":"97","author":"LJ Brandt","year":"2002","unstructured":"Brandt LJ, Bjorkman D, Fennerty MB, et al.: Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002, 97(Suppl 11):S7-S26.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"15_CR28","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1053\/j.gastro.2003.10.007","volume":"126","author":"Y Scarlett","year":"2004","unstructured":"Scarlett Y: Medical management of fecal incontinence. Gastroenterology 2004, 126(Suppl 1):S55-S63.","journal-title":"Gastroenterology"},{"key":"15_CR29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1572-0241.2003.07306.x","volume":"98","author":"NJ Talley","year":"2003","unstructured":"Talley NJ: Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol 2003, 98:750\u2013758. This is another comprehensive review of the agents used in treatment of IBS. Again, it does not touch specifically on FD, but many of the agents are the same.","journal-title":"Am J Gastroenterol"},{"key":"15_CR30","unstructured":"Lexi-Comp Online. http:\/\/www.lexi.com.libproxy. lib.unc.edu. Accessed February 11, 2006, for all medications discussed above."},{"key":"15_CR31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2036.2001.00937.x","volume":"15","author":"T Poynard","year":"2001","unstructured":"Poynard T, Regimbeau C, Benhamou Y: Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001, 15:355\u2013361.","journal-title":"Aliment Pharmacol Ther"},{"key":"15_CR32","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ajhp\/62.7.700","volume":"62","author":"DE Baker","year":"2005","unstructured":"Baker DE: Rationale for using serotonergic agents to treat irritable bowel syndrome. Am J Health Syst Pharm 2005, 62:700\u2013711.","journal-title":"Am J Health Syst Pharm"},{"key":"15_CR33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1053\/gast.2001.21177","volume":"120","author":"D Friedel","year":"2001","unstructured":"Friedel D, Thomas R, Fisher RS: Ischemic colitis during treatment with alosetron. Gastroenterology 2001, 120:557\u2013560.","journal-title":"Gastroenterology"},{"key":"15_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14740338.1.1.1","volume":"1","author":"PE Hyman","year":"2002","unstructured":"Hyman PE, Garvey TQ, 3rd: Return of alosetron. Expert Opin Drug Saf 2002, 1:1\u20134.","journal-title":"Expert Opin Drug Saf"},{"key":"15_CR35","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1517\/14656566.4.11.2089","volume":"4","author":"EA Mayer","year":"2003","unstructured":"Mayer EA, Bradesi S: Alosetron and irritable bowel syndrome. Expert Opin Pharmacother 2003, 4:2089\u20132098.","journal-title":"Expert Opin Pharmacother"},{"key":"15_CR36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1572-0241.2004.04097.x","volume":"99","author":"JA Cole","year":"2004","unstructured":"Cole JA, Cook SF, Sands BE, et al.: Occurrence of colon ischemia in relation to irritable bowel syndrome. Am J Gastroenterol 2004, 99:486\u2013491.","journal-title":"Am J Gastroenterol"},{"key":"15_CR37","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/j.1572-0241.2004.30509.x","volume":"99","author":"WD Chey","year":"2004","unstructured":"Chey WD, Chey WY, Heath AT, et al.: Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2004, 99:2195\u20132203.","journal-title":"Am J Gastroenterol"},{"key":"15_CR38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00002018-200427050-00001","volume":"27","author":"V Andresen","year":"2004","unstructured":"Andresen V, Hollerbach S: Reassessing the benefits and risks of alosetron: What is its place in the treatment of irritable bowel syndrome? Drug Saf 2004, 27:283\u2013292.","journal-title":"Drug Saf"},{"key":"15_CR39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/13543784.14.2.185","volume":"14","author":"WD Chey","year":"2005","unstructured":"Chey WD, Cash BD: Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea. Expert Opin Investig Drugs 2005, 14:185\u2013193.","journal-title":"Expert Opin Investig Drugs"},{"key":"15_CR40","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/gut.45.6.889","volume":"45","author":"SD Hearing","year":"1999","unstructured":"Hearing SD, Thomas LA, Heaton KW, Hunt L: Effect of cholecystectomy on bowel function: a prospective, controlled study. Gut 1999, 45:889\u2013894.","journal-title":"Gut"},{"key":"15_CR41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","volume":"108","author":"JL Jackson","year":"2000","unstructured":"Jackson JL, O\u2019Malley PG, Tomkins G: Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000, 108:65\u201372. This is a key paper summarizing the available evidence on the use of antidepressant medications in functional bowel disorders.","journal-title":"Am J Med"},{"key":"15_CR42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11894-005-0025-x","volume":"7","author":"GW Citters Van","year":"2005","unstructured":"Van Citters GW, Lin HC: Management of small intestinal bacterial overgrowth. Curr Gastroenterol Rep 2005, 7:317\u2013320.","journal-title":"Curr Gastroenterol Rep"},{"key":"15_CR43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1572-0241.2006.00458.x","volume":"101","author":"AI Sharara","year":"2006","unstructured":"Sharara AI, Aoun E, Abdul-Baki H, et al.: A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol 2006, 101:326\u2013333.","journal-title":"Am J Gastroenterol"},{"key":"15_CR44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/01.mog.0000182861.11669.4d","volume":"21","author":"EF Verdu","year":"2005","unstructured":"Verdu EF, Collins SM: Irritable bowel syndrome and probiotics: from rationale to clinical use. Curr Opin Gastroenterol 2005, 21:697\u2013701.","journal-title":"Curr Opin Gastroenterol"},{"key":"15_CR45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cpr.2005.07.003","volume":"26","author":"AC Butler","year":"2006","unstructured":"Butler AC, Chapman JE, Forman EM, Beck AT: The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev 2006, 26:17\u201331.","journal-title":"Clin Psychol Rev"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-006-0015-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-006-0015-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-006-0015-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:57:03Z","timestamp":1559437023000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-006-0015-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.1007\/s11938-006-0015-6","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}